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Abstract
Background: Inadequate protein intake (PI), containing a sub-optimal source of essential amino acids (EAAs), and
reduced appetite are contributing factors to age-related sarcopenia. The satiating effects of dietary protein per se
may negatively affect energy intake (EI), thus there is a need to explore alternative strategies to facilitate PI without
compromising appetite and subsequent EI.
Methods: Older women completed two experiments (EXP1 and EXP2) where they consumed either a Bar (565 kJ),
a Gel (477 kJ), both rich in EAAs (7.5 g, 40% L-leucine), or nothing (Control). In EXP1, participants (n = 10, 68 ±
5 years, mean ± SD) consumed Bar, Gel or Control with appetite sensations and appetite-related hormonal
responses monitored for one hour, followed by consumption of an ad libitum breakfast (ALB). In EXP2, participants
(n = 11, 69 ± 5 years) ingested Bar, Gel or Control alongside an ALB.
Results: In EXP1, EI at ALB was not different (P = 0.674) between conditions (1179 ± 566, 1254 ± 511, 1206 ± 550 kJ
for the Control, Bar, and Gel respectively). However, total EI was significantly higher in the Bar and Gel compared to
the Control after accounting for the energy content of the supplements (P < 0.0005). Analysis revealed significantly
higher appetite Area under the Curve (AUC) (P < 0.007), a tendency for higher acylated ghrelin AUC (P = 0.087), and
significantly lower pancreatic polypeptide AUC (P = 0.02) in the Control compared with the Bar and Gel. In EXP2, EI
at ALB was significantly higher (P = 0.028) in the Control (1282 ± 513 kJ) compared to the Bar (1026 ± 565 kJ) and
Gel (1064 ± 495 kJ). However, total EI was significantly higher in the Bar and Gel after accounting for the energy
content of the supplements (P < 0.007).
Conclusions: Supplementation with either the Bar or Gel increased total energy intake whether consumed one
hour before or during breakfast. This may represent an effective nutritional means for addressing protein and total
energy deficiencies in older women.
Trial registration: Clinical trial register: retrospectively registered, ISRCTN12977929 on.
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Background
Optimum protein and energy intakes in older adults are
important for promoting good health [1–3], recovery
from illness [4] and maintenance of function [5–7].
When requirements are not met the risk of sarcopenia
increases [8, 9]. Characterised by a progressive decline in
skeletal muscle mass and strength [10, 11], sarcopenia is
known to increase morbidity, mortality, and associated
health care costs [12]. Sarcopenia has been recently
recognised as a disease [13], while its high prevalence
has brought attention towards identifying strategies that
can assist older individuals in meeting their dietary
needs. It has been suggested that current recommen-
dations of 0.8 g.kg-1.d−1 for dietary protein should be
increased to 1.0–1.6 g.kg-1.d−1 and that a higher pro-
tein threshold of at least 25–30 g protein per-meal
should be encouraged in this age group to promote
anabolism [8, 14–19]. However, reductions in taste
and appetite [20, 21], slower gastric emptying, and
changes in appetite-regulating hormones [22] that can
occur irrespective of disease [23] present unique
challenges to this population. A diminished anabolic
response to protein [15, 24, 25] and the increased
requirements caused by inflammatory and catabolic
responses to diseases of ageing may compound this
further. It is worth noting that a large proportion
older individuals do not even meet the existing rec-
ommendations for protein, however deficiencies tend
to be larger in women than in men [26–28]. Taking
into account the higher frailty rates that are observed
in women with lower protein intakes [29, 30], it is
imperative that adequate protein intake is maintained
with advancing age. Paradoxically, protein also has a
known and well-established satiating effect that can
compromise dietary energy intake [17, 31, 32], which
adds complexity to interventions that seek to increase
both energy and protein intakes.
In response, a number of nutritional interventions in-
volving supplementation with protein or essential amino
acids (EAAs) have so far shown ambiguous results; some
indicating promise [3, 7, 33–36] but others not [37, 38].
Supplementation with the essential amino acid L-leucine
(leucine) has attracted specific interest due to its cru-
cial role in the regulation of muscle protein synthesis
[39, 40]. In particular, there is general agreement that
older individuals have a higher leucine threshold and
that they would benefit from larger amounts of leu-
cine either within a meal or as a protein/EAAs sup-
plement [7, 17, 36, 41–45]. However, there has been
little consideration of the satiating effects of EAAs-
based nutritional supplements enriched with leucine
and no studies have examined the impact on appetite
and concurrent mealtime energy intake nor the prac-
tical aspects of palatability. Therefore, the main aim
of the current crossover design study was to investigate to
what extent acute supplementation of EAAs-based nutri-
tional supplements containing 7.5 g of EAAs (40%
leucine) affects the appetite and subsequent dietary energy
intake of older women. A secondary aim was to investi-
gate the potential mechanism of action through the meas-
urement of appetite-regulating gut hormones acylated
ghrelin, pancreatic polypeptide (PP) and peptide tyrosine
tyrosine (PYY).
Methods
This investigation involved two experiments that were
conducted in accordance with the guidelines laid down
in the Declaration of Helsinki. All procedures were
approved by the University Faculty Research Ethics
Committee and written informed consent was obtained
from all participants. The trial was registered at ISRCTN
registry with a trial registry number of ISRCTN12977929.
Study participants were independently living female older
adults aged between 60 and 80 years, free from vascular
and metabolic disease, and of good health. Participants
were excluded if they smoked, had used estrogens within
the previous three months, or were lactose intolerant. In
each study, participants were recreationally active but
were not engaged in a regular programme of exercise
training.
For both experiments, participants were asked to rec-
ord all food and fluid consumed in the 24 h prior to the
first experimental trial and replicate this for all subse-
quent trials. Participants were also asked to avoid alco-
hol and intensive physical activity during the same time
period. All trials commenced between 07:30 am and
09:00 am after an overnight fast of at least 10 h. Partici-
pants exerted themselves minimally when travelling to
the laboratory, using motorised transport where possible.
Verbal confirmation of the dietary and exercise stand-
ardisation was obtained at the beginning of each experi-
mental trial.
Preliminary screening and anthropometry
In both experiments, the first visit to the laboratory in-
volved an initial briefing and screening process. Partici-
pants were provided with information on the study
procedures and given instructions with regards to the
dietary replication and pre-test requirements. Baseline
stature (to the nearest cm) and body mass (to the near-
est kg) were recorded by a stadiometer (SECA Alpha,
Birmingham, UK) and scales (SECA Alpha 770, Birming-
ham, UK). Resting heart rate (RHR), systolic and
diastolic blood pressure (SBP and DBP, respectively)
were measured alongside these variables, using a heart
rate monitor (Polar, Kempele, Finland) and a sphygmo-
manometer (Accoson, Essex, UK). Self-reported physical
activity levels were estimated using the short-form
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International Physical Activity Questionnaire (IPAQ)
[46]. The weekly total estimated energy expenditure for
our sample group was 5437 ± 6286 MET minutes with a
range of 537–17,940 MET minutes. The descriptive
characteristics for both study populations are provided
in Table 1.
Experimental protocol
In the first experiment (EXP1), older women (n = 10)
completed three trials each separated by a minimum of
one week in a randomised, crossover design. Appetite
sensations and plasma acylated ghrelin, PP and PYY re-
sponses to a 37.5 g bar (BAR, 565 kJ), a 50 ml gel (GEL,
478 kJ) or nothing (CON) were investigated over the
course of one hour, followed by an ad libitum breakfast
(ALB). Both the BAR and GEL provided 7.5 g of EAAs
with the same amino acid concentration as the 40% leu-
cine EAAs mixture previously described by Ispoglou et
al. [7]. The EAAs were purchased from Fagron UK Ltd.,
and the remaining materials from a main supermarket
chain in UK (J Sainsbury plc). The finished products
were developed in collaboration between our institute
and a Product Developer to the Food Industry based at
Askham Bryan College (UK). The key nutritional infor-
mation per 100 g of finished product was:
- For the BAR: energy 1511 kJ, fat 8.2 g, carbohydrate
47.5 g, protein 25.4 g of which 15 g was EAAs, fibre
2.8 g, salt 0.2 g.
- For the GEL: energy 967 kJ, fat 0.0 g, carbohydrate
44.7 g, protein 15 g which was entirely due to the
EAAs content, fibre 0.5 g, salt 0.2 g.
Baseline appetite perceptions and a baseline blood
sample were collected five minutes prior to each condi-
tion, with participants instructed to consume each sup-
plement within a five minute period. Once the breakfast
was consumed, participants were asked to provide final
appetite and palatability perceptions.
In the second experiment (EXP2), older women (n = 11)
completed three trials separated by a minimum of one
week in a randomised, crossover design. Participants were
asked to consume either a BAR, GEL, or CON immedi-
ately prior to an ALB meal. Appetite and palatability rat-
ings were obtained five min prior to each condition, with
participants asked to provide postprandial ratings 20 min
after starting the breakfast.
The allocation sequence was computer-generated
using a freely available online tool (GraphPad). Recruit-
ment stopped when the required sample size of partici-
pants was achieved. An overview of the experimental
design and testing procedures for both EXP1 and EXP2
is provided in Fig. 1.
Ad libitum breakfast
In both experiments, the ad libitum breakfast was identi-
cal, with an energy density of 4.9 kJ/g and a macronutri-
ent composition of 59% carbohydrate, 18% protein and
23% fat. Meal preparation involved mixing of 54 g of
porridge oats (Oatso Simple Original, Quaker Oats) with
292 ml semi-skimmed milk. The mixture was then
cooked in a microwave for two and a half minutes at
700 W. Participants consumed the breakfast in isolation
to avoid any social influence on food intake. A bowl of
the aforementioned meal was provided by an investiga-
tor and participants were instructed to eat until ‘com-
fortably full’, with no time limit set for eating. This bowl
was replaced before the participant had emptied it, with
minimal interaction and this process continued until the
participant was comfortably full. Food intake was calcu-
lated as the weighted difference in food before and after
eating [47].
Appetite and palatability assessment
In both studies, appetite perceptions (hunger, satisfac-
tion, fullness and prospective food consumption) were
measured using 100 mm visual analogue scales with de-
scriptors anchored at each end [48]. A composite appe-
tite score was calculated as the mean value of the four
appetite perceptions after inverting the values for satis-
faction and fullness. Palatability ratings (visual appeal,
smell, taste, aftertaste and pleasantness) were obtained
for the supplements and the ad libitum breakfast. A
composite palatability score was calculated as the mean
value of the palatability subscales [48].
Blood sampling and biochemical analysis
In EXP1, participants rested in a semi-supine position
for a minimum of five minutes before a cannula
(Venflon, Becton Dickinson, Helsinborg, Sweden) was
inserted into an antecubital vein by a trained phlebotom-
ist. Blood samples were obtained at baseline (five min
prior to each condition) and five, 30 and 60 min after
supplement ingestion for the determination of plasma
concentrations of acylated ghrelin, pancreatic polypep-
tide (PP), and peptide tyrosine tyrosine (PYY). Plasma
C-reactive protein (CRP) concentration was also mea-
sured at baseline. At each time-point, samples were
drawn into two pre-chilled 4.9 ml K3 ethylenediamine-
tetraacetic acid (EDTA) monovettes (Sarstedt, Germany).
To prevent the degradation of acylated ghrelin, one
Table 1 Descriptive characteristics for the study populations in
experiment one and two. Data presented as mean ± SD
Variable Experiment one (n = 10) Experiment two (n = 11)
Age (years) 68.4 ± 4.5 69.3 ± 5.2
Height (cm) 161.8 ± 5.4 161.7 ± 5.2
Body mass (kg) 65.2 ± 8.1 65.0 ± 7.7
BMI (kg.m2) 24.9 ± 3.1 24.9 ± 3.0
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monovette was prepared with a 50 μl solution of potas-
sium phosphate buffer (PBS), P-hydroxymercuribenzoic
acid (PHMB) and sodium hydroxide (NaOH). These
monovettes were spun at 1000 x g for 10 min at 4 °C
(ALC PK131R, Milan, Italy). The plasma supernatant
was then pipetted into an Eppendorf tube and 100 μl of
1 M hydrochloric acid was added per millilitre of plasma
to preserve acylated ghrelin (Hosoda et al., 2004). Fol-
lowing this, aliquots were spun at 1000 x g for 5 min at
4 °C and then stored in Eppendorf tubes at −80 °C for
subsequent analysis. The accompanying monovettes
were spun at 1000 x g for 10 min at 4 °C, with the
resulting plasma supernatant pipetted into Eppendorf
tubes for storage at −80 °C for subsequent analysis.
Commercially available enzyme-linked immunosorbent
assay (ELISA) kits were used to determine plasma con-
centrations of acylated ghrelin (SPI BIO, Montigney le
Bretonneux, France), PP (Millipore, Watford, UK), PYY
(Millipore, Watford, UK), and CRP (IBL International
GmbH, Germany), respectively. To eliminate interassay
variation, samples from each participant were analysed
in the same run. The within-batch coefficients of vari-
ation for each assay were 10.2%, 7.8%, 7.1% and 6.8% for
acylated ghrelin, PP, PYY and CRP, respectively.
In a subset of participants (n = 2), untreated plasma
samples were used to determine circulating amino acid
concentrations. Prior to analysis, an internal standard
(norleucine) was added to the plasma and proteins were
removed by way of ultrafiltration. As previously
described [7], plasma amino acids were analysed by gas
chromatography mass spectrometry (GC-MS) after cat-
ion exchange and derivatisation as ethoxycarbonyl ethyl
esters.
Statistics
Data were analysed using SPSS for Windows (Version
22.0, IBM Corp., Armonk, NY). Time averaged area under
the curve (AUC) values were calculated using the trapez-
oidal method. One-way repeated measures ANOVA was
used to examine trial-based differences in energy intake
and baseline CRP, as well as baseline and AUC values for
appetite perceptions and plasma concentrations of acyl-
ated ghrelin, PP and PYY. Differences in the palatability of
the supplements in experiment one was compared using
paired t-tests and differences in the palatability of the
breakfast meals in experiment two were compared using a
one-way ANOVA. Normality was assessed by the Shapiro-
Wilk test. Where significant effects were found, post-hoc
analysis using Holm-Bonferroni correction for multiple
comparisons was performed. The sample sizes employed
within this study were deemed sufficient to detect a sig-
nificant difference in energy intake between trials as the
primary outcome measure for each experiment. Calcula-
tions were performed using G*Power with a meaningful
difference in energy intake established as 500 kJ according
to previous research [49], achieving 80% power with 10
participants, and based on the standard deviation for a
similar ad libitum meal to that used within the present
Fig. 1 A schematic representation of the design for experiment one (EXP1) and two (EXP2). The three conditions consisted of either a bar (BAR),
gel (GEL), or nothing (CON). Black arrows = appetite rating assessment; syringe picture = blood samples. Ad libitum breakfast (ALB)
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study [47]. Results in the text and tables are presented as
mean (SD). Graphical representations of results are shown
as mean (SEM) to avoid distortion of the graphs. Statis-




Energy intake at the ALB was not significantly different
between trials (CON 1179 ± 564, BAR 1254 ± 511, GEL
1206 ± 550 kJ; P = 0.674). However, total energy intake
was significantly higher in the BAR and GEL than the
CON after accounting for the energy content of the sup-
plements (P < 0.0005; Fig. 2). Visual appeal, smell, taste,
aftertaste and palatability of the breakfast did not differ
between trials (all P > 0.206).
Appetite
Composite appetite ratings did not differ between trials
at baseline (CON 72 ± 10, BAR 67 ± 18, GEL 73 ±
13 mm; P = 0.486). One-way ANOVA revealed a signifi-
cant time-averaged appetite AUC main effect (CON 72
± 15, BAR 49 ± 19, GEL 59 ± 17 mm; P = 0.008; Fig. 3).
Post-hoc analysis, demonstrated that appetite ratings
were significantly higher in CON vs BAR (P = 0.012) and
GEL vs BAR (P = 0.009). There was no difference be-
tween trials in AUC ratings for sweet (P = 0.135),
savoury (P = 0.930), fatty (P = 0.961) or salty (P = 0.448)
food preferences.
Plasma gut hormone concentrations
Plasma concentration of measured gut hormones are
shown in Fig. 4abc. There were no significant differ-
ences between trials for fasting PYY (P = 0.587),
acylated ghrelin (P = 0.456), PP (P = 0.544) or CRP
concentrations (CON 1.14 ± 0.85, BAR 1.46 ± 1.35,
GEL 1.27 ± 1.14 μg.mL−1; P = 0.398).
Time-averaged AUC for PYY did not differ between
trials (CON 34 ± 19, BAR 46 ± 27, GEL 50 ± 31 pg.mL
−1; P = 0.236; Fig. 4a). There was a tendency for lower
time-averaged acylated ghrelin AUC in the BAR and
GEL trials compared with CON (CON 204 ± 124,
BAR 171 ± 83, GEL 169 ± 104 pg.mL−1; P = 0.087; Fig.
4b) and PP AUC was significantly higher in BAR and
GEL than CON (CON 44 ± 102, BAR 72 ± 128, GEL
57 ± 102 pg.mL−1; P = 0.020; Fig. 4c).
Plasma amino acid concentrations
Mean plasma amino acid concentration during the
three conditions is given in Table 2. Maximum plasma
leucine concentrations were reached at 30 and 60 min
post-ingestion in both the BAR (332.5 ± 65.4 and 409.1
± 48.0 μMol.L−1 at 30 and 60 min respectively) and
GEL (209.5 ± 77.5 and 390.2 ± 80.4 μMol.L−1 at 30 and
60 min respectively) conditions. The corresponding
values for the CON were 64.7 ± 9.9 and 65.2 ± 9.4
μMol.L−1.
Fig. 2 Total energy intake in the control, bar and gel trials (experiment
one). Data are displayed as individual responses (a) and mean (SEM)
(b), n = 10
Fig. 3 Composite appetite ratings in the control (▼), bar (●) and gel
(○) trials (experiment one). Values are mean (SEM), n = 10
Ispoglou et al. Nutrition Journal  (2017) 16:75 Page 5 of 10
Palatability of supplements
Paired t-tests revealed higher ratings of visual appeal
(P < 0.0005) and smell (P = 0.035) for the BAR
compared with the GEL (visual appeal: BAR 80 ± 17
versus GEL 23 ± 20; smell: BAR 68 ± 16 versus GEL 45
± 21). There were no differences between supplements
for ratings of taste, aftertaste or overall palatability (all
P > 0.277).
Experiment two
Composite appetite ratings did not differ between trials
at baseline (CON 77 ± 11, BAR 70 ± 15, GEL 70 ±
18 mm; P = 0.141).
Energy intake at the ALB was significantly higher in the
CON compared with the BAR and GEL (CON 1282 ±
513, BAR 1026 ± 565, GEL 1064 ± 495 kJ; P = 0.028). How-
ever, total energy intake was significantly higher in the
BAR and GEL than the CON after accounting for the en-
ergy content of the supplements (P = 0.007; Fig. 5).
Visual appeal, smell, taste, aftertaste and palatability of
the breakfast did not differ between trials (all P > 0.159).
Experiment one and two
Participants in both experiments complied fully with the
dietary and exercise standardisation requirements for
the 24-h period preceding each testing trial. In cases
where participants did not replicate the 24-h diet and
exercise records completed for the first experimental
trial, testing was rearranged.
Discussion
To our knowledge, this is the first study to demonstrate
that supplementation of two unique essential amino acid
blends, administered as either a bar or a gel, enabled
older women to increase energy intake regardless of
whether the supplements were taken one hour before or
alongside an ad libitum breakfast meal (ALB). The com-
position of the supplements was optimised for the target
population with each supplement containing 7.5 g of
EAAs, the equivalent of approximately 15 g of high
quality protein, and high leucine content (~3 g). The
current composition did not negatively affect palatability,
smell, taste and aftertaste when consumed alongside a
typical porridge-based breakfast meal. Therefore, our
data suggests that the current formulations and modes
of ingestion can be an effective alternative dietary means
Fig. 4 Plasma peptide YY (a), acylated ghrelin (b) and pancreatic
polypeptide (c) concentrations in the control (▼), bar (●) and gel
(○) trials (experiment one). Values are mean (SEM). N = 10 for peptide
YY and pancreatic polypeptide concentrations. N = 9 for plasma
acylated ghrelin concentrations
Table 2 Concentration of amino acids (μMol.L−1) in experiment
one. Data are displayed as mean (SD), n = 2. Area under the
curve (AUC)
Amino acids Control (AUC) Bar (AUC) Gel (AUC)
Leucine 67.9 ± 6.6 276.5 ± 27.6 206.3 ± 7.9
Isoleucine 19.6 ± 2.4 55.6 ± 5.2 40.9 ± 0.0
Valine 115.7 ± 12.0 193.2 ± 32.1 153.7 ± 2.7
Alanine 274.0 ± 28.5 334.3 ± 54.7 308.7 ± 68.2
Glycine 92.1 ± 51.3 98.7 ± 44.6 90.3 ± 29.6
Proline 217.2 ± 26.5 243.7 ± 15.6 220.0 ± 7.6
Phenylalanine 20.8 ± 0.4 33.4 ± 1.5 27.5 ± 0.8
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of protein ingestion, for women who need to enhance
total daily protein intake or a high quality protein intake
per meal, without negatively affecting energy intake.
In experiment one, energy intake at ALB was not
significantly different between conditions while the
additional energy provided by either the bar or the gel
(565 and 477 kJ respectively) contributed to achieving
significant elevations in total energy intake. Supplemen-
tation one hour before the ALB did not result in any
subsequent reductions in food volume, as has shown in
other cases where use of dense nutritional supplements
results in compensatory caloric redistribution [50]. In
our study, a small to moderate reduction in volume of
food eaten was expected, when the supplements were
consumed one hour before the ALB, yet this did not
happen. As expected, appetite ratings during the one-
hour post-supplement ingestion were significantly higher
in the control condition. However, the magnitude of in-
crease was not adequate to cause subsequent reductions
in food consumed during the ALB. Neither the bar nor
the gel affected the food cravings of participants, since
no differences were observed between the preferences
for sweet, savoury, fatty, or salty foods.
Food protein sources or protein supplements may in-
crease satiety and reduce energy intake [17, 31, 32]. There-
fore, key objective was to develop nutritional supplements
with minimal satiating effects and optimised EAAs con-
centration. The tested supplements were enriched with
EAAs instead of protein in an attempt to address deficits
in protein intake without reducing energy intake. This is
important since protein-energy malnutrition is high in
institutionalised older individuals [51–53], where large
dietary deficiencies [38] puts them at greater risk for com-
plications and death in proportion to the degree of
protein-energy deficiencies [54]. It is also true of commu-
nity living older populations where the prevalence of mal-
nutrition has been reported as 5–8% [55] and up to 66%
considered at nutritional risk [56].
The satiating effects of dietary protein, which results in
subsequent reductions in energy intake, partly through in-
creases in peptide tyrosine-tyrosine (PYY), and post-
prandial fullness [17, 32] pose additional challenges. In
contrast, our own study indicated no significant differ-
ences in PYY concentration between conditions. Alterna-
tively, plasma acylated ghrelin concentrations tended to
be lower after the consumption of both the bar and the
gel, and PP concentrations were significantly elevated dur-
ing these conditions. Such changes would be expected as
means to aid digestion [57] but were much lower than
what would typically be observed following consumption
of a high protein meal [58]. The lower appetite percep-
tions observed in concordance with these changes in
appetite-regulating hormones was not sufficient to alter
energy intake during the ALB, which suggests that the
supplements provided in this study may help to increase
overall energy intakes.
Our data showed that large increases in plasma
concentration of amino acids reached peak values
within 30–60 min post-ingestion. This highlights the
highly efficient digestion and absorption rates of both
supplements comparable to supplementation with
amino acids [59] or higher amounts of high quality
protein [44, 60]. One of the reasons whey protein ele-
vates muscle protein synthesis to a greater extent
than lower quality proteins [44, 61] is due to higher
leucine content [62, 63], which plays a crucial role in
the regulation of muscle protein synthesis [39]. In our
case, leucine concentration values were much higher
than those of high quality proteins therefore the
current supplements could be an effective means to
optimise muscle protein synthesis rates in older
people. Indeed, studies have shown that muscle pro-
tein synthetic rate in the old is higher with increasing
leucine content either in mixtures of EAAs [41] or
whey protein [43, 44]. Furthermore, studies have pro-
vided good evidence for the prophylactic role of
EAAs [33, 64] or EAAs enriched with leucine [7, 65].
Fig. 5 Total energy intake in the control, bar and gel trials (experiment
two). Data are displayed as individual responses (a) and mean (SEM)
(b), n = 11
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More importantly, it has been observed that older in-
dividuals with higher leucine intakes maintain lean
mass over a six year period while those with lower
intakes do not [66].
In experiment two, energy intake at ALB was signifi-
cantly lower than the control, which demonstrated
adequate sensitivity of the breakfast meal to detect
changes in energy intake. Nevertheless, total energy
intake was significantly higher in the experimental
conditions when energy from the supplements was
accounted for. Therefore, both the bar and the gel can
be taken alongside food as means to enhance total en-
ergy intake and the anabolic effect of food. Ingestion of
the supplements alongside food can be particularly ef-
fective since older individuals tend to receive at break-
fast and lunch less than 23 g of protein per meal [67]
with protein deficiencies being much larger at break-
fast. Recommendations suggest the amount of protein
per meal should be at least 25–30 g [17, 18] or approxi-
mately 0.4 g.kg-1.BM−1 [68], with high leucine content
[69]. Further studies have provided additional support
for the need for higher protein intake per meal where it
has been shown that one to two daily meals containing
30–45 g of protein each were associated with more
favourable gains in lean tissue mass and strength of
older men and women [14]. Similarly, Gregorio et al.
[19] also observed that older women with higher diet-
ary protein intakes had better physical performance and
body composition than women with lower protein in-
takes. Supplementation with whey protein (30 g daily
for a period of 2 years) in healthy older women [37] on
the other hand did not result in gains in muscle mass
and physical function and this may be because protein
intakes at baseline were higher than current recom-
mendations. However, it is not known if there was a re-
duction in total energy intake in the protein group due
to the potential satiating effects of protein [17, 32]. The
current supplements can facilitate an overall increase in
protein and leucine intake without negatively affecting
energy intake. In line with experiment one the supple-
ments were received well by all participants. The palat-
ability of the breakfast was considered “good” on
scoring, and not affected by concurrent consumption of
the supplements during the meal. Despite an adequate
sample size for the current study, there is a need for
further research to confirm the generalisability and
reproducibility of our findings in larger clinical and
non-clinical populations, as well as in men. Using a
validated breakfast meal, our findings confirm that both
supplements can facilitate an acute increase in protein
and energy intake. However, it is still unknown how
daily intakes may be affected when the supplements
are taken alongside other main meals of varied
composition.
Conclusions
In conclusion, our results demonstrate that ingestion of
oral nutritional supplements containing 7.5 g of EAAs
enriched with 40% leucine (3 g) increased total energy
intake whether consumed one hour before or during an
ad libitum breakfast. This may represent an effective
nutritional means for addressing protein and total en-
ergy deficiencies in older women.
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